N-{4-(2-([1,1'-Biphenyl]-4-yl)-4-methylthiazol-5-yl)-pyrimidin-2-yl}morpholine-4-carboximidamide

ID: ALA4212292

PubChem CID: 145965765

Max Phase: Preclinical

Molecular Formula: C25H24N6OS

Molecular Weight: 456.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(-c2ccc(-c3ccccc3)cc2)sc1-c1ccnc(NC(=N)N2CCOCC2)n1

Standard InChI:  InChI=1S/C25H24N6OS/c1-17-22(21-11-12-27-25(29-21)30-24(26)31-13-15-32-16-14-31)33-23(28-17)20-9-7-19(8-10-20)18-5-3-2-4-6-18/h2-12H,13-16H2,1H3,(H2,26,27,29,30)

Standard InChI Key:  TXYMXMGOEICJCD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   15.7721   -4.1547    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9516   -4.0686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6159   -3.3150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1007   -2.6475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.9212   -2.7335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2569   -3.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1078   -4.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9283   -4.9943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6230   -5.5758    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8025   -5.4898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3177   -6.1573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4972   -6.0712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1615   -5.3176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6463   -4.6501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4668   -4.7361    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2676   -7.5233    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.6002   -8.0084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9327   -7.5236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1875   -6.7389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0125   -6.7388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7024   -6.0716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6007  -10.4834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8862  -10.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8860   -9.2460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6004   -8.8334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3149   -9.2457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3151  -10.0707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6009  -11.3084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3155  -11.7207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3156  -12.5457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6012  -12.9584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8867  -12.5460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8865  -11.7210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  7  8  2  0
  7  9  1  0
  1  7  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 16 20  1  0
 19 21  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 22 27  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 28 33  2  0
 22 28  1  0
 17 25  1  0
 12 20  1  0
  9 10  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4212292

    ---

Associated Targets(Human)

HRT-18 cell line (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecium (13803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.58Molecular Weight (Monoisotopic): 456.1732AlogP: 4.92#Rotatable Bonds: 4
Polar Surface Area: 87.02Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.07CX LogP: 4.52CX LogD: 4.51
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.33Np Likeness Score: -1.37

References

1. Hagras M, Mohammad H, Mandour MS, Hegazy YA, Ghiaty A, Seleem MN, Mayhoub AS..  (2017)  Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA).,  60  (9): [PMID:28436655] [10.1021/acs.jmedchem.7b00392]

Source